Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lexaria Bioscience (LEXX) Debt Ratio (2016 - 2022)

Lexaria Bioscience's Debt Ratio history spans 8 years, with the latest figure at 0.0 for Q2 2022.

  • Quarterly results put Debt Ratio at 0.0 for Q2 2022, up 21.56% from a year ago — trailing twelve months through May 2022 was 0.0 (up 21.56% YoY), and the annual figure for FY2021 was 0.0, down 98.11%.
  • Debt Ratio for Q2 2022 was 0.0 at Lexaria Bioscience, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.05 in Q4 2020 to a low of 0.0 in Q3 2021.
  • The 5-year median for Debt Ratio is 0.0 (2018), against an average of 0.01.
  • The sharpest move saw Debt Ratio plummeted 99.39% in 2018, then skyrocketed 2164.18% in 2021.
  • Year by year, Debt Ratio stood at 0.01 in 2018, then surged by 121.72% to 0.01 in 2019, then soared by 300.74% to 0.05 in 2020, then plummeted by 98.77% to 0.0 in 2021, then surged by 30.0% to 0.0 in 2022.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.0, 0.0, and 0.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.